Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as paclitaxel poliglumex and capecitabine, work
in different ways to stop the growth of tumor cells, either by killing the cells or by
stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill
more tumor cells.
PURPOSE: This phase II trial is studying how well giving paclitaxel poliglumex together with
capecitabine works in treating patients with metastatic breast cancer.